MYCN and hepatocellular carcinoma: Consistently, MYCN expression marked an EpCAM+ CSC-like subpopulation, which was selectively depleted by acyclic retinoid (ACR), a promising chemopreventive agent against the recurrence of HCC after curative treatment (17, 32).